Home/ Blog/ Before the storm: what the world has learnt ab...

Prevention in Psychiatry·

Before the storm: what the world has learnt about preventing psychosis

Cover for Preventing Psychosis, from the Prevention in Psychiatry series by Dr. Saurabh Kumar, Healthy Minds India

How Melbourne's PACE clinic began psychosis prevention, what 30 years of research shows, and a practical evidence-based plan for early psychosis care in Bihar.

In this article 18
  1. The PACE story: a clinic built for the in-between
  2. What happens to young people seen at a high-risk clinic?
  3. From one clinic to a worldwide movement
  4. What actually helps? An honest look at the evidence
  5. My reading of the World Psychiatry blueprint
  6. How a high-risk service works
  7. Reach out
  8. Open the door
  9. Assess carefully
  10. Support the whole person
  11. Stay in touch
  12. Bringing it home: a practical plan for Bihar
  13. The language we use matters
  14. Early signs families should not ignore
  15. A last word, to families like Ritesh's
  16. Worried about someone?
  17. References
  18. About this article

Prevention in Psychiatry › Preventing psychosis

Thirty years ago, a small clinic in Melbourne asked a radical question: what if we could meet young people before psychosis takes hold? This is the story of that idea, what the evidence now shows, and how we might bring it home to Bihar.

About a 14-minute read · Part of the Prevention in Psychiatry series

A story I have heard, in many versions
Ritesh is nineteen and in his second year of college in Patna. Over six months he has changed. He sleeps through the day and lies awake at night. He has stopped attending lectures because he feels people on the road are looking at him and talking about him - though he admits he cannot be sure. He has started smoking ganja with friends "to calm down". His parents first took him to a baba, then to a general physician who prescribed sleeping tablets. By the time they reached a psychiatrist, nearly a year had passed.
Composite illustration drawn from common clinical patterns; not a real individual.

Ritesh was not yet psychotic. He still knew, somewhere, that his suspicions might not be true. He was in what psychiatrists now call a clinical high-risk state for psychosis - a period of subtle but real change that, for some young people, comes before illnesses such as schizophrenia. For decades, nobody looked for this period. People like Ritesh were simply sent home until the illness was impossible to miss.

That changed in Melbourne in the 1990s. And the lesson that followed - sometimes hopeful, sometimes humbling - is one every family, doctor and policymaker in India should know.

The PACE story: a clinic built for the in-between

In 1994, Professor Patrick McGorry, Alison Yung and their colleagues opened the Personal Assessment and Crisis Evaluation (PACE) clinic in Melbourne. Their idea was simple and bold: rather than waiting for a first psychotic episode, they would offer care to young people who were struggling and showing early warning signs.1

To do this, they needed a way to tell who was genuinely at risk. They developed the ultra high-risk criteria - now called clinical high risk for psychosis - which identify three groups of young people seeking help.1,2 The 2021 World Psychiatry blueprint on preventive psychiatry summarises how common each group is today:5

~85%Attenuated symptoms

Unusual thoughts, suspiciousness or perceptual changes that are milder than full psychosis - the person still has some doubt about them.

~10%Brief intermittent psychosis

Short-lived psychotic symptoms that resolve on their own within a week.

~5%Genetic risk with decline

A close relative with psychosis, or schizotypal traits, plus a clear fall in day-to-day functioning.

The early results were striking. In PACE's first cohorts, around four in ten young people meeting these criteria developed psychosis within a year.2 Later, the landmark PACE 400 study followed 416 young people for up to 15 years. About 35% developed a psychotic disorder over ten years - most in the first two years, but some much later.3

The highest risk is in the first two years - but the door should stay open long after.

Just as importantly, PACE taught us that these young people were not simply "at risk". They were already suffering. Most had depression or anxiety, many had dropped out of study or work, and nearly all were asking for help.5,6 The clinic's purpose was never only to prevent a diagnosis. It was to relieve present distress and protect a young life.

What happens to young people seen at a high-risk clinic?

The most recent meta-analysis pooled 130 studies and more than 9,000 young people at clinical high risk.4 Choose a time point to see how many, out of 100, developed psychosis.

25 in 100

developed a psychotic disorder within three years.

That also means most did not. Many recovered; some continued to live with depression, anxiety or difficulties in functioning. A high-risk assessment is not a prediction of schizophrenia - it is an invitation to care.

Cumulative risk: about 15% at 1 year, 25% at 3 years and 35% at 10 years (Salazar de Pablo et al., JAMA Psychiatry 2021).

From one clinic to a worldwide movement

PACE's model spread across the world. By 2017-18, specialist services were caring for more than 22,000 young people across Western Europe, North America, East Asia, Australia, South America and Africa.5 Each programme added something new.

1994 · Melbourne, Australia
PACE clinic

The first dedicated service; developed the ultra high-risk criteria and long-term follow-up.1,3

1990s · Cologne, Germany
Early Recognition and Intervention Centre (FETZ)

Showed that subtle "basic symptoms" - changes in thinking and perception the person notices in themselves - can predict schizophrenia years ahead.9

Late 1990s · New Haven, USA
PRIME clinic, Yale

Developed the widely used SIPS interview, and ran an early medication trial that ultimately taught caution about using antipsychotics for prevention.10

2001 · London, UK
OASIS service

Built outreach with schools, GPs and youth services across south London, and showed how a community-facing service can find young people earlier.7

2004 · Manchester, UK
EDIE trial

One of the first randomised trials of cognitive therapy for high-risk young people.8

2008-2016 · North America
NAPLS consortium

Pooled eight centres to study who develops psychosis, and built an individual risk calculator.11

2010 · Europe
EPOS study

Tested prediction across six centres in four European countries.12

2010s · Shanghai, China
SHARP programme

Brought high-risk care to Asia and validated prediction tools in Chinese youth.13

2018 · Europe
PRONIA

Combined clinical data, brain imaging and genetics with machine learning to predict functional outcomes.14

2020s · Five continents
AMP SCZ (ProNET and PRESCIENT)

The largest prospective study of clinical high risk, spanning 43 sites in 13 countries, searching for biomarkers to guide future treatment trials.15

2024 · India
Community screening, Telangana (AIIMS New Delhi team)

A two-stage screen of rural and urban Indian youth identified young people at high risk who went on to develop psychosis at a markedly higher rate - evidence that the approach can work in India.16

India's own early-intervention story began with first-episode psychosis. The Schizophrenia Research Foundation (SCARF) in Chennai, working with Canadian colleagues, showed in the 2000s that focused early care is feasible and effective in an Indian setting.17 What we still lack, especially in eastern India, are services designed for the period before the first episode.

What actually helps? An honest look at the evidence

This is where we must be careful. Early trials were very encouraging, but larger and better studies have tempered some of that optimism. Families deserve the plain truth.

ApproachWhat the research shows
Specialist assessment and monitoringStrong
Structured interviews reliably identify a group at much higher risk than the general population, and specialist services shorten the time before untreated psychosis is recognised and treated.4,6,23
Treating present problems - depression, anxiety, sleep, family stressStrong, and recommended
Most high-risk young people have these difficulties, and they deserve treatment in their own right.5,6
Cognitive behavioural therapy (CBT), with family involvementRecommended, but not proven superior
Recommended by NICE.22 Earlier trials suggested CBT reduces transition,8 but the latest network and Cochrane meta-analyses found no robust evidence that any specific intervention prevents psychosis better than good needs-based care.18,19
Omega-3 fish oilsNot supported
A promising early trial20 was not confirmed by the larger NEURAPRO study.21
Antipsychotic medicines for preventionNot recommended
Not advised simply to prevent psychosis, given side-effects and lack of benefit.5,10,22
Reducing cannabis useStrong rationale
Daily high-potency cannabis use is linked with around five times the odds of psychotic disorder.26
Cost-effectivenessEncouraging
Early intervention in psychosis, including high-risk care, appears cost-effective, though more studies are needed - especially in low-resource settings.5,25

Why, then, do these services matter if no single therapy has been proven to prevent psychosis? Because when psychosis does develop, it is picked up early - and the longer psychosis goes untreated, the worse the long-term outcome tends to be.23,24 And because the young people who come to them are in genuine distress today, and they receive care they would otherwise not have had.

My reading of the World Psychiatry blueprint

In 2021, six leading researchers - including Paolo Fusar-Poli, Vikram Patel and John Ioannidis - published a blueprint for preventive psychiatry in young people.5 I have read it many times, and three of its conclusions shape how I think about psychosis prevention.

First, the high-risk model is the best-validated form of indicated prevention in psychiatry. The criteria are robustly linked with later psychosis, and the services built around them have spread worldwide. Of all our preventive tools, this is the most mature.

Second, the evidence for specific preventive treatments is weaker than we once hoped. The authors are refreshingly direct that a noble aim does not justify claims the data do not support. Future progress depends on larger trials, better prediction and personalised care.

Third, high-risk clinics catch only part of the picture. Most people who develop psychosis never pass through such a clinic; many first show depression or anxiety. That is why the authors argue for services that are transdiagnostic, youth-friendly, linked to primary care, and combined with public-health action on drivers such as cannabis, poverty and adversity.

The paper's limits are worth naming too. It is written for researchers, and almost all of its evidence comes from wealthy countries. Translating it to Bihar - where most families first approach a faith healer or a general physician, and where specialist services are scarce - needs a model shaped for our realities.

How a high-risk service works

Whatever the country, successful programmes share the same five steps.1,6,7

1

Reach out

Teach schools, colleges, GPs and families the early signs.

2

Open the door

Easy referral - by phone, by a teacher, or by the young person themselves.

3

Assess carefully

A trained clinician uses a structured interview such as CAARMS or SIPS.

4

Support the whole person

Therapy, family work, sleep, substance use, study and work.

5

Stay in touch

Monitor for at least two years, with an open door afterwards.

Bringing it home: a practical plan for Bihar

Bihar has one of the youngest populations in India, and the years between 15 and 30 are when psychosis most often begins. Yet a young person here may wait many months - sometimes years - between the first change and the first psychiatric assessment. Drawing on the programmes above and on the realities of our clinics, this is the model I believe we can build.

  1. Train the first doorsMost families first go to a general physician, a school teacher, a coaching-centre counsellor or a faith healer. Short training for these first contacts - what to notice, where to refer - can shorten the delay more than any new building.
  2. Screen in two steps, not oneA brief self-report questionnaire in Hindi, followed by a structured interview for those who screen positive, is the approach validated in Indian youth.16 It avoids both missing young people and frightening those who are simply stressed.
  3. Assess with trained cliniciansDistinguishing an attenuated symptom from ordinary stress or cultural belief requires skill and context. Structured tools such as CAARMS or SIPS, used by trained staff, keep assessments consistent.5
  4. Offer needs-based careCBT and family psychoeducation; treatment for depression, anxiety and sleep; help with study, exams and employment; and frank conversations about ganja, bhang and other cannabis use.22,26
  5. Hold back on medicines that are not neededAntipsychotics are reserved for those who develop psychosis, not prescribed simply because of risk.22
  6. Follow up for at least two yearsRegular review, with a clear route back if things worsen later.3
  7. Measure, learn and shareRecord who comes, how they do and what helps - so that Bihar contributes its own evidence instead of borrowing everyone else's.

The language we use matters

Stigma is a real fear for families. Research suggests young people often worry less about a "risk" label than clinicians assume, but words still matter.5 In our clinic, we talk about early support, not about "pre-schizophrenia".

Avoid saying
Say instead
“He is going to get schizophrenia.”
“He is going through changes that deserve care, and most young people in this situation do not develop psychosis.”
“It is just a phase; leave him alone.”
“Let us get it checked early - it costs little to be sure.”
“Someone has done something to her.”
“Her brain is under strain. Help is available, and it works best early.”

Early signs families should not ignore

These changes, lasting several weeks, are worth an early conversation with a psychiatrist. They do not mean psychosis is inevitable.

  • Becoming unusually suspicious, or feeling watched or talked about
  • Hearing, seeing or sensing things others do not, even briefly
  • Thoughts that feel strange, muddled or "not my own"
  • A marked fall in studies or work, without a clear reason
  • Withdrawing from friends and family; losing interest in everything
  • Sleep turned upside down - awake at night, sleeping by day
  • Neglecting self-care and appearance
  • Heavier use of ganja, bhang or alcohol to cope
  • A family history of psychosis together with any of the above
  • Any talk of hopelessness or not wanting to live - seek help the same day

A last word, to families like Ritesh's

When Ritesh's parents finally sat in front of me, his mother asked the question I hear most often: "Doctor sahab, did we come too late?" I told her what I believe the evidence allows me to say. It is rarely too late to help. But the earlier we meet a young person, the more of their life we can protect - their studies, their friendships, their confidence, their future.

Psychosis prevention began as a single clinic in Melbourne. Today it is a worldwide effort, honest about its limits and stubborn in its hope. Bihar's young people deserve to be part of it.

Dr. Saurabh Kumar
MD (Psychiatry) AIIMS New Delhi · Associate Professor & HOD, RDJM Medical College · Ex-Assistant Professor, PMCH Patna · Consultant, Healthy Minds Clinic, Patna

Worried about someone?

An early assessment is a conversation, not a verdict. Healthy Minds Clinic, House No. 46/B, Sahdeo Mahto Marg, near Sri Krishna Puri Park (Children's Park), Patna 800001. Open Monday, Tuesday, Wednesday, Friday and Sunday, 9 a.m. to 7 p.m. For appointments only - in an emergency, call 112.

References

The small numbers in the text link to the sources below.

  1. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin. 1996;22(2):283-303.
  2. Yung AR, Phillips LJ, Yuen HP et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophrenia Research. 2003;60(1):21-32.
  3. Nelson B, Yuen HP, Wood SJ et al. Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry. 2013;70(8):793-802.
  4. Salazar de Pablo G, Radua J, Pereira J et al. Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis. JAMA Psychiatry. 2021;78(9):970-978.
  5. Fusar-Poli P, Correll CU, Arango C, Berk M, Patel V, Ioannidis JPA. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021;20(2):200-221.
  6. Fusar-Poli P, Salazar de Pablo G, Correll CU et al. Prevention of psychosis: advances in detection, prognosis, and intervention. JAMA Psychiatry. 2020;77(7):755-765.
  7. Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK. Outreach and support in South London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. European Psychiatry. 2013;28(5):315-326.
  8. Morrison AP, French P, Walford L et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. British Journal of Psychiatry. 2004;185:291-297.
  9. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry. 2001;58(2):158-164.
  10. McGlashan TH, Zipursky RB, Perkins D et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry. 2006;163(5):790-799.
  11. Cannon TD, Cadenhead K, Cornblatt B et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry. 2008;65(1):28-37.
  12. Ruhrmann S, Schultze-Lutter F, Salokangas RKR et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European Prediction of Psychosis Study. Archives of General Psychiatry. 2010;67(3):241-251.
  13. Zhang T, Li H, Tang Y et al. Validating the predictive accuracy of the NAPLS-2 psychosis risk calculator in a clinical high-risk sample from the SHARP (Shanghai At Risk for Psychosis) program. American Journal of Psychiatry. 2018;175(9):906-908.
  14. Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S et al. Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: a multimodal, multisite machine learning analysis (PRONIA). JAMA Psychiatry. 2018;75(11):1156-1172.
  15. Wannan CMJ, Nelson B, Addington J et al. Accelerating Medicines Partnership Schizophrenia (AMP SCZ): rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis. Schizophrenia Bulletin. 2024;50(3):496-512.
  16. Tikka SK, Malathesh BC, Spoorthy MS et al. Identification of youth at clinical high-risk for psychosis: a community-based study from India. Early Intervention in Psychiatry. 2024.
  17. Rangaswamy T, Mangala R, Mohan G, Joseph J, John S. Early intervention for first-episode psychosis in India. East Asian Archives of Psychiatry. 2012;22(3):94-99.
  18. Davies C, Cipriani A, Ioannidis JPA et al. Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry. 2018;17(2):196-209.
  19. Bosnjak Kuharic D, Kekin I, Hew J et al. Interventions for prodromal stage of psychosis. Cochrane Database of Systematic Reviews. 2019;11:CD012236.
  20. Amminger GP, Schäfer MR, Papageorgiou K et al. Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry. 2010;67(2):146-154.
  21. McGorry PD, Nelson B, Markulev C et al. Effect of ω-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial. JAMA Psychiatry. 2017;74(1):19-27.
  22. National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management (CG178). London: NICE; 2014.
  23. Oliver D, Davies C, Crossland G et al. Can we reduce the duration of untreated psychosis? A systematic review and meta-analysis of controlled interventional studies. Schizophrenia Bulletin. 2018;44(6):1362-1372.
  24. Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry. 2014;205(2):88-94.
  25. Aceituno D, Vera N, Prina AM, McCrone P. Cost-effectiveness of early intervention in psychosis: systematic review. British Journal of Psychiatry. 2019;215(1):388-394.
  26. Di Forti M, Quattrone D, Freeman TP et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI). Lancet Psychiatry. 2019;6(5):427-436.

About this article

Dr. Saurabh Kumar

Written and medically reviewed by

Dr. Saurabh Kumar

  • MD (Psychiatry) AIIMS New Delhi
  • Associate Professor & HOD, RDJM Medical College
  • Ex-Assistant Professor, PMCH Patna
  • Consultant, Healthy Minds Clinic, Patna
Published
8 October 2026
  • For general education only; it does not replace an individual assessment by a qualified clinician.
  • Risk figures describe groups, not individuals.
  • The case described is a composite and does not identify any person.
  • Programme descriptions are summarised from published literature.

© 2026 Healthy Minds India, Patna

preventing psychosis early psychosis clinical high risk for psychosis PACE clinic cannabis and psychosis early intervention in psychosis psychiatrist in Patna

Medically reviewed by Dr. Saurabh Kumar, Consultant Neuropsychiatrist, Healthy Minds India, Patna. This article is for general education and is not a substitute for a personal consultation. To discuss your situation, book an appointment or contact the clinic.

Disclaimer: all characters and events depicted in this blog are entirely fictional. Any resemblance to actual persons, living or dead, is purely coincidental. The content is intended for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for medical concerns.

Keep reading

More from the clinic.

Reading about it is a start. Talking about it is the step that changes things.

A calm, unhurried consultation and a clear plan forward - for a child, a teenager or an adult.